Screening for T1D risk to reduce DKA is not economically viable.

Screening for T1D risk to reduce DKA is not economically viable.

Item
http://www.wikidata.org/entity/Q53342893
Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da studyRebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity.Prediction of type 1 diabetes using a genetic risk model in the Diabetes Autoimmunity Study in the Young.Pathways to reduce diabetic ketoacidosis with new onset type 1 diabetes: Evidence from a regional pediatric diabetes center: Auckland, New Zealand, 2010 to 2014.Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease.A population-wide applicable HLA-DQ2 and DQ8 genotyping using DNA from dried blood spots and duplex allele-specific qPCR amplification.Understanding Pre-Type 1 Diabetes: The Key to Prevention.
P2860

Screening for T1D risk to reduce DKA is not economically viable.

Item
http://www.wikidata.org/entity/Q53342893
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Screening for T1D risk to reduce DKA is not economically viable.
@en
Screening for T1D risk to reduce DKA is not economically viable.
@nl
type
label
Screening for T1D risk to reduce DKA is not economically viable.
@en
Screening for T1D risk to reduce DKA is not economically viable.
@nl
prefLabel
Screening for T1D risk to reduce DKA is not economically viable.
@en
Screening for T1D risk to reduce DKA is not economically viable.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Screening for T1D risk to reduce DKA is not economically viable.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698